Stephen Neal is a Psychiatry physician. OpenAlex indexes 8 publications with 493 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year202519 payments
- Neurocrine BioSciences, Inc.Program year202521 payments
- Vanda Pharmaceuticals Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
91%SSRI21.7%Trazodone Hcl29%Fluoxetine Hcl24%Sertraline Hcl18%Citalopram Hbr9%Escitalopram Oxalate8%Fluvoxamine Maleate6%Fluoxetine Dr5%Paroxetine Hcl3%Part D<11 patientsAtypical Antipsychotic12%Aripiprazole34%Quetiapine Fumarate15%Lurasidone Hcl14%Olanzapine12%Risperidone6%Fanapt5%Quetiapine Fumarate Er4%Rexulti3%Vraylar3%Abilify Maintena3%Clozapine2%Part D<11 patients+ 26 more classes in this area
Cardiovascular
8.8%Central alpha-2 Adrenergic Agonist6.7%Clonidine Hcl46%Guanfacine Hcl45%Guanfacine Hcl Er9%Part D<11 patientsalpha-Adrenergic Blocker1.4%Prazosin Hcl82%Doxazosin Mesylate18%Part D<11 patients+ 2 more classes in this area
Respiratory
0.2%Other antihistamines for systemic use0.2%Cyproheptadine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice
Expert Opinion on Pharmacotherapy
2019 - Using sertraline in postpartum and breastfeeding: balancing risks and benefits
Expert Opinion on Drug Safety
2018
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Dennis Charney, MD
Icahn School of Medicine at Mount Sinai
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”